LinkedIn Audience Network prefers IAS to offer native ad brand safety
By Akshay Kedari  Date: 2020-05-26

LinkedIn Audience Network prefers IAS to offer native ad brand safety

Integral Ad Science (IAS), a renowned leader in digital ad verification, has recently announced its agreement with the LinkedIn Audience Network to offer brand safety to native ads on mobile, web, in-app and desktop. The integration tends to utilize the predictive technology of the IAS as well as the real-time data to ensure that the campaigns activated with the help of the LinkedIn Audience Network are brand safe and fraud-free.

The marketers have been relying on the Audience Network of LinkedIn to be able to reach the millions of high-value professionals through third-party, trusted publishers. After the integration of IAS, the advertisements will be able to have an extra layer of brand protection to be able to deliver the message confidently in major trusted environments.

The integration will be filtering out major risk inventory automatically before they place a bid for different campaigns on the LinkedIn Audience Network.

IAS’ Chief Executive Officer, Lisa Utzschneider said that the relation between the firms brings in together the strengths of highly trusted platforms for joining forces so that the marketers will be able to activate the ads confidently over the brand-safe inventory, looking for the correct environments for different campaigns. 

Utzschneider further added that the company is capable of providing the best level of brand safety protection for various markets on its platform as the first platform-wide brand safety partner of the LinkedIn Audience network.

The marketers have found it even more important to be able to secure the best possible return from the investments across media. IAS tends to give out full coverage to make sure that whenever they place an ad, it reaches out to real people in the correct environments with the capability of making a major impact.

 

Source Credit- https://www.benzinga.com/pressreleases/20/05/n16103073/ias-chosen-to-provide-brand-safety-across-the-linkedin-audience-network

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...